Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »Pfizer’s Covid-19 vaccine could be authorized by October, analysts say
Text size Jeenah Moon / Getty Images Pfizer hopes to get emergency food authorization from the Food and Drug Administration for its Covid-19 vaccine, produced in collaboration with BioNTech, in October – a timeline that is possible, and not the only positive for the biotech industry, according to a Mizuho …
Read More »A tidal wave of news about covid vaccine is on the market
Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »CureVac and EU in advanced talks for 225 million doses of Covid-19 vaccine
Shares of CureVac NV rose Thursday after the German biotech company said it was in advanced talks to deliver at least 225 million doses of a potential Covid-19 vaccine to EU member states. CureVac said talks with the EC, the executive arm of the European Union, include an option to …
Read More »For Covid-19 vaccine, J&J plans 60,000 subject pivotal trial
Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »